Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia

Molecular Biology Reports

Volumn 37, Issue 3, 2010, Pages 1467-1475

  Hou, Xiangqian ^a   Wu, Xuejun ^a   Ma, Junxi ^a   Lv, Xinhui ^a   Jin, Xing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Erythropoietin; Limb ischemia; Marrow stromal cells

Indexed keywords

ERYTHROPOIETIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; HINDLIMB; LIMB ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; STROMA CELL; THERAPY EFFECT; TREATMENT RESPONSE; ANALYSIS OF VARIANCE; ANGIOGRAPHY; ANIMAL; BONE MARROW TRANSPLANTATION; DRUG EFFECT; ISCHEMIA; LASER DOPPLER FLOWMETRY; LIMB; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; TRANSPLANTATION; VASCULARIZATION;

RATTUS;

ANALYSIS OF VARIANCE; ANGIOGRAPHY; ANIMALS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; EXTREMITIES; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; STROMAL CELLS;

EID: 77951884438     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9541-3     Document Type: Article

References (37)

1. Li TS, Ito H, Hayashi M et al (2005) Cellular expression of integrin-beta 1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 65:64-72. doi: 10.1016/j.cardiores.2004.08.019
2. Koshikawa M, Shimodaira S, Yoshioka T et al (2006) Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: A pilot study. Curr Med Res Opin 22:793-798. doi:10.1185/03007 9906X1000078
3. Semenza GL (2006) Therapeutic angiogenesis: Another passing phase? Circ Res 98:1115-1116. doi:10.1161/01.RES.00002234 85.43020.9e
4. Yla-Herttuala S, Alitalo K (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9:694-701. doi:10. 1038/nm0603-694
5. Shintani S, Murohara T, Ikeda H et al (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903. doi:10.1161/hc2301. 092122
6. Al-Khaldi A, Al-Sabti H, Galipeau J et al (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75:204-209. doi:10.1016/S0003-4975(02) 04291-1
7. Ozawa CR, Banfi A, Glazer NL et al (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113:516-527
8. Ware JA, Simmon M (1997) Angiogenesis in ischemia heart disease. Nat Med 3:158-164. doi:10.1038/nm0297-158
9. Casscells W (2000) Growth factor therapies for vascular injury and ischemia. Circulation 101:118-121
10. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967. doi:10.1126/science.275.5302.964
11. Takahashi M, Li TS, Suzuki R et al (2006) Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291:H886-H893. doi:10.1152/ajpheart.00142.2006
12. Schaper W, Ito WD (1996) Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911-919
13. Gorge G, Schmidt T, Ito BR, Pantely GA, Schaper W (1989) Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis. Basic Res Cardiol 84:524-535. doi:10.1007/BF01908204
14. Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427. doi: 10.1073/pnas.070046397
15. Isner JM, Kalka C, Kawamoto A et al (2001) Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair. Ann N Y Acad Sci 953:75-84
16. Conget PA, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progentior cells. J Cell Physiol 181:63-73. doi:10.1002/(SICI)1097-4652(199910) 181:1\67::AID-JCP7[3.0.CO;2-C
17. Ohgushi H, Caplan AI (1999) Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res 48:913-927. doi:10.1002/(SICI)1097- 4636(1999)48:6\913::AID -JBM22[3.0.CO;2-0
18. Tang J, Xie Q, Pan G et al (2006) Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothorac Surg 30:353-361. doi:10.1016/j.ejcts.2006.02. 070
19. Jiang Y, Jahagirdar BN, Reinhardt RL et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49. doi:10.1038/nature00870
20. Le Blanc K (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5:485-489. doi:10.1080/ 14653240310003611
21. Kobayashi T, Hamano K, Li TS et al (2000) Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89:189-195. doi:10.1006/ jsre.2000.5828
22. Zhang D, Zhang F, Zhang Y et al (2006) Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction. Cardiology 108:228-236. doi:10.1159/000096803
23. Maiese K, Li F, Chong ZZ (2005) New avenues of exploration for erythropoietin. JAMA 293:90-95. doi:10.1001/jama.293.1.90
24. Chong ZZ, Kang JQ, Maiese K (2002) Angiogenesis and plasticity: Role of erythropoietin in vascular systems. J Hematother Stem Cell Res 11:863-871. doi:10.1089/152581602321080529
25. Chedrawy EG, Wang JS, Nguyen DM et al (2002) Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: Anatomic basis for functional improvements. J Thorac Cardiovasc Surg 124:584-590. doi:10.1067/mtc.2002.12 2544
26. Heeschen C, Aicher A, Lehmann R et al (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346. doi:10.1182/blood-2003- 01-0223
27. Hamano K, Li TS, Kobayashi T et al (2001) The induction of angiogenesis by the implantation of autologous bone marrow cells: A novel and simple therapeutic method. Surgery 130:44-54. doi:10.1067/msy.2001.114762
28. Ozawa T, Toba K, Kato K et al (2006) Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J Mol Cell Cardiol 40:629-638. doi:10.1016/j.yjmcc.2006.01.023
29. Kinnaird T, Stabile E, Burnett MS et al (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549. doi: 10.1161/01.CIR.0000124062.31102.57
30. Rafiee P, Shi Y, Su J et al (2005) Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100:187-197. doi:10.1007/s00395-004-0508-1
31. Jaquet K, Krause K, Tawakol-Khodai M et al (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64:326-333. doi:10.1006/mvre.2002.2426
32. Solaroglu I, Solaroglu A, Kaptanoglu E et al (2003) Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22
33. Smith KJ, Bleyer AJ, Little WC et al (2003) The cardiovascular effects of erythropoietin. Cardiovasc Res 59:538-548. doi: 10.1016/S0008-6363(03)00468-1
34. Mancini DM, Katz SD, Lang CC et al (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107:294-299. doi:10.1161/01. CIR.0000044914.42696.6A
35. Kobayashi K, Kondo T, Inoue N et al (2006) Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler Thromb Vasc Biol 26:1465-1472. doi:10.1161/01.ATV. 0000223865.64812.26
36. Le Blanc K, Pittenger M (2005) Mesenchymal stem cells: Progress toward promise. Cytotherapy 7:36-45. doi:10.1080/1465 3240510018118
37. van der Meer P, Voors AA, Lipsic E et al (2004) Erythropoietin in cardiovascular diseases. Eur Heart J 25:285-291. doi:10.1016/ j.ehj.2003.11.017